Furthermore, the hyperproliferative quality of FLT3-ITD mut AML leading to higher average blast percentages in the peripheral blood could allow the apheresis machine to more efficiently remove circulating blasts into the apheresate. This evidence concerns the gene FLT3 and acute myeloid leukemia.